Literature DB >> 16880184

The Black Death and AIDS: CCR5-Delta32 in genetics and history.

S K Cohn1, L T Weaver.   

Abstract

Black Death and AIDS are global pandemics that have captured the popular imagination, both attracting extravagant hypotheses to account for their origins and geographical distributions. Medical scientists have recently attempted to connect these two great pandemics. Some argue that the Black Death of 1346-52 was responsible for a genetic shift that conferred a degree of resistance to HIV 1 infection, that this shift was almost unique to European descendents, and that it mirrors the intensity of Black Death mortality within Europe. Such a hypothesis is not supported by the historical evidence: the Black Death did not strike Europe alone but spread from the east, devastating regions such as China, North Africa, and the Middle East as much or even more than Europe. Further, in Europe its levels of mortality do not correspond with the geographic distribution of the proportion of descendents with this CCR5 gene. If anything, the gradient of Black Death mortality sloped in the opposite direction from that of present-day genotypes: the heaviest casualties were in the Mediterranean, the very regions whose descendents account for the lowest incidences of the HIV-1 resistant allele. We argue that closer collaboration between historians and scientists is needed to understand the selective pressures on genetic mutation, and the possible triggers for changes in genetic spatial frequencies over the past millennia. This requires care and respect for each other's methods of evaluating data.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16880184     DOI: 10.1093/qjmed/hcl076

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  10 in total

1.  HIV infection and AIDS among young women in South Africa.

Authors:  Adamson S Muula
Journal:  Croat Med J       Date:  2008-06       Impact factor: 1.351

2.  Functional CCR5 receptor protects patients with arthritis from high synovial burden of infecting Chlamydia trachomatis.

Authors:  Hervé C Gérard; Jessica A Stanich; Cynthia E Oszust; Judith A Whittum-Hudson; John D Carter; H Ralph Schumacher; Alan P Hudson
Journal:  Am J Med Sci       Date:  2010-12       Impact factor: 2.378

Review 3.  Chemokine receptor CCR5: from AIDS to atherosclerosis.

Authors:  K L Jones; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

4.  Historic, demographic, and genetic evidence for increased population frequencies of CCR5Delta32 mutation in Croatian Island isolates after lethal 15th century epidemics.

Authors:  Zrinka Biloglav; Lina Zgaga; Mladen Smoljanović; Caroline Hayward; Ozren Polasek; Ivana Kolcić; Veronique Vitart; Tatijana Zemunik; Vesna Boraska; Vesela Torlak; Rosanda Mulić; Darko Ropac; Ivica Grković; Diana Rudan; Smiljana Ristić; Maja Barbalić; Harry Campbell; Alan F Wright; Igor Rudan
Journal:  Croat Med J       Date:  2009-02       Impact factor: 1.351

5.  The great opportunity: Evolutionary applications to medicine and public health.

Authors:  Randolph M Nesse; Stephen C Stearns
Journal:  Evol Appl       Date:  2008-02       Impact factor: 5.183

6.  Generation of CCR5-defective CD34 cells from ZFN-driven stop codon-integrated mesenchymal stem cell clones.

Authors:  Krissanapong Manotham; Supreecha Chattong; Anant Setpakdee
Journal:  J Biomed Sci       Date:  2015-03-26       Impact factor: 8.410

7.  Predominance of the heterozygous CCR5 delta-24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface.

Authors:  Vic Arendt; Mathieu Amand; Gilles Iserentant; Morgane Lemaire; Cécile Masquelier; Gilles F Ndayisaba; Chris Verhofstede; Etienne Karita; Susan Allen; Andy Chevigné; Jean-Claude Schmit; Danielle Perez Bercoff; Carole Seguin-Devaux
Journal:  J Int AIDS Soc       Date:  2019-09       Impact factor: 5.396

8.  Spatial and temporal analysis of the COVID-19 incidence pattern in Iran.

Authors:  Zeinab Hazbavi; Raoof Mostfazadeh; Nazila Alaei; Elham Azizi
Journal:  Environ Sci Pollut Res Int       Date:  2020-11-14       Impact factor: 4.223

9.  ABO blood grouping and COVID 19: Is there any correlation in suspectibility?

Authors:  Sushma Bommanavar; T Smitha
Journal:  J Oral Maxillofac Pathol       Date:  2020-09-09

Review 10.  C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection.

Authors:  Fatima Barmania; Michael S Pepper
Journal:  Appl Transl Genom       Date:  2013-05-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.